Hatem A El Mezayen

Hatem A El Mezayen

Auto-generated profile, based on publicly available information

Hatem A El Mezayen


Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2016 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
DODiaa Osman
Diaa Osman
OAOmnia Ali
Omnia Ali
MOManar Obada
Manar Obada
HEHatem El‐Mezayen
Hatem El‐Mezayen
HEHala El‐Said
Hala El‐Said

1 April 2015 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
HEHatem A. El-Mezayen
Hatem A. El-Mezayen
SHSalem Habib
Salem Habib
HMHamdi F. Marzok
Hamdi F. Marzok
MSMostafa H. Saad
Mostafa H. Saad
To date, liver biopsy has been the gold standard used for the assessment of liver fibrosis in patients with chronic hepatitis C. Our aim was to evaluate the diagnostic performance of a panel of simple blood markers of liver fibrosis and the development a novel score to replace liver biopsy. Liver biochemical profile including transaminases, bilirubin, alkaline phosphatase, and albumin, in addition to platelet count, was evaluated using standard methods in 305 chronic hepatitis C patients. Serum type IV collagen and laminin were assayed using the ELISA technique. Liver biopsies were performed. Statistical analyses were carried out by logistic regression and receiver operating characteristic curves to assess and compare the diagnostic accuracy of blood markers. A stepwise combination algorithm was developed and validated in 317 additional patients. The Fibrosis Discriminant Score (FDS) was developed combining collagen, laminin, aspartate aminotransferase/platelet ratio index, and albumin. FDS produced an area under receiver operating characteristic curve of 0.831 for significant fibrosis, 0.791 for advanced fibrosis, and 0.881 for cirrhosis. The FDS was correctly classified in 82% of patients with significant fibrosis with 79% sensitivity and 88% specificity at cut-off 0.66 or more. Similar results were obtained in a validation study in which, of 317 patients, liver biopsy could have been avoided in 81%. A simple fibrosis index can be useful to select hepatitis C virus-infected patients with a very low risk of significant fibrosis in whom the protocol of liver biopsies may be avoided.

17 June 2019 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
DMDalia Medhat
Dalia Medhat
HEHatem A. El-Mezayen
Hatem A. El-Mezayen
MEMehrez E. El-Naggar
Mehrez E. El-Naggar
AFAbdel Razik Farrag
Abdel Razik Farrag
MAMohamed Essameldin Abdelgawad
Mohamed Essameldin Abdelgawad
MKMarina Hanna Kamal
Marina Hanna Kamal

1 January 2019 in Toxicology Reports
Verified
Journal Article
Open access
NMNaima Mohamed
Naima Mohamed
HAHanan Farouk Aly
Hanan Farouk Aly
HEHatem Abdel Moneim El-Mezayen
Hatem Abdel Moneim El-Mezayen
HEHadeer E. El-Salamony
Hadeer E. El-Salamony
Alternative and complimentary usage of the natural compound has raised hopes of finding curative options for liver hepatocarcinogenesis. In the present study, the curative effect of bee honey against diethylnitrosamine (DEN) (50 mg/kg) and carbon tetrachloride (CCl4) (2 mg/Kg)-induced hepatocellular carcinoma (HCC) in male rats in the presence or absence of some chemotherapeutic drugs, Cisplatin (Cis), Cyclophosphamide (CY) and 5- Fluorouracil (5-FU) were investigated. The obtained results demonstrated that treatment with DEN/CCl4 caused oxidative stress as assigned by the increase in malondialdehyde (MDA) and fall in glutathione (GSH) content. Meantime detraction in the antioxidants, including superoxide dismutase (SOD), catalase (CAT), glutathione-s-transferase (GST) and glutathione peroxidase (GPx) was observed. Also, the results showed induction of inflammation as reflected by an increase in the levels of both α- fetoprotein and α- fucosidase in the liver. This was accompanied by changes in the hepatic function biomarkers which characterized by the increased levels of transaminases (AST, ALT), alkaline phosphatase (ALP) and γ-Glutamyl transferase (γ-GT) and decrease in total protein content in the serum. In conclusion, the combination of the selected drugs and bee honey may be an effective chemo- preventive and therapeutic strategy for treating DEN and CCl4-induced HCC.

1 December 2012 in Toxicon
Verified
Journal Article
Closed access
AWA.F. Wahby
A.F. Wahby
EMEl-Sayed M.E. Mahdy
El-Sayed M.E. Mahdy
HEHatem A. El-Mezayen
Hatem A. El-Mezayen
WSWalaa H. Salama
Walaa H. Salama
AAAzza M. Abdel-Aty
Azza M. Abdel-Aty
AFAfaf S. Fahmy
Afaf S. Fahmy

28 January 2011 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
HAHamed I. Ali
Hamed I. Ali
AKAbdel Meguid Kassem
Abdel Meguid Kassem
AWAbdel Hady Abdel Wahab
Abdel Hady Abdel Wahab
HEHatem A El-Mezayen
Hatem A El-Mezayen
HSHayaat Sharad
Hayaat Sharad
SRShaimaa Abdel Rahman
Shaimaa Abdel Rahman